Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME-DM
2006-001430-40Phase 4Active
- Sponsor
- University Hospital Department of Cardiology
- Start
- Jun 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin, atorvastatin and carvedilol in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospital Department of Cardiology. Primary endpoint: Major clinical cardiac events. Started Jun 2006; status: active.
02
Drugs
aspirinatorvastatincarvedilol
03
Conditions
coronary arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-001430-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001430-40.